Repligen Corporation (RGEN) financial statements (2021 and earlier)

Company profile

Business Address 41 SEYON STREET
WALTHAM, MA 02453
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7175281941741427258
Cash and cash equivalents7175281941741225435
Short-term investments    201823
Receivables7144362817128
Inventory, net of allowances, customer advances and progress billings95554239251812
Inventory95554239251812
Prepaid expense5311011
Deferred costs  0000 
Deposits current assets      0
Other current assets9110000
Other undisclosed current assets51121111
Total current assets:90264227624318410381
Noncurrent Assets
Operating lease, right-of-use asset2526
Property, plant and equipment67483222151415
Long-term investments and receivables     24
Long-term investments     24
Intangible assets, net (including goodwill)905681462472892729
Goodwill618468327327601414
Intangible assets, net (excluding goodwill)287213135145301315
Restricted cash and investments    000
Other noncurrent assets1006   
Deferred tax assets, net4    
Other undisclosed noncurrent assets23     
Total noncurrent assets:1,0017584995011054347
TOTAL ASSETS:1,9031,400775744289146128
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities70452625211915
Accounts payable1711107574
Accrued liabilities5333161816127
Employee-related liabilities      4
Taxes payable      1
Debt2444103    
Business combination, contingent consideration, liability      1
Deferred revenue and credits   0
Other undisclosed current liabilities5     (6)
Total current liabilities:3194813025211911
Noncurrent Liabilities
Long-term debt and lease obligation26260 9995  
Long-term debt, excluding current maturities 233 9995  
Operating lease, liability2627
Liabilities, other than long-term debt122928456
Deferred tax liabilities, net2525   
Other liabilities1242456
Other undisclosed noncurrent liabilities2730     
Total noncurrent liabilities:55292291279956
Total liabilities:3743401591521202317
Stockholders' equity
Stockholders' equity attributable to parent1,5291,060616592169123112
Common stock1100000
Additional paid in capital1,4611,068643629242203198
Accumulated other comprehensive income (loss)2(15)(12)(6)(14)(9)(6)
Retained earnings (accumulated deficit)666(16)(32)(60)(72)(81)
Total stockholders' equity:1,5291,060616592169123112
TOTAL LIABILITIES AND EQUITY:1,9031,400775744289146128

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues3662701941411058464
Revenue, net1411058464
Cost of revenue(157)(119)(87)(67)(50)(39)(28)
Cost of goods and services sold(157)(119)(87)(67)(47)(35)(28)
Gross profit:21015110874544436
Operating expenses(140)(115)(82)(60)(38)(30)(27)
Other undisclosed operating income      2
Operating income:70362614161411
Nonoperating income (expense)(11)(10)(5)(0)(1)(0)0
Investment income, nonoperating2520000
Other nonoperating income (expense)(0)(0)0(1)(1)(0)0
Interest and debt expense(12)(6)(7)(6)(4)(0)(0)
Income from continuing operations before equity method investments, income taxes:4721157121311
Other undisclosed income from continuing operations before income taxes1267    
Income from continuing operations before income taxes:5926217121311
Income tax expense (benefit)1(5)(5)21(0)(4)(3)
Net income available to common stockholders, diluted:602117281298

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income:602117281298
Other comprehensive loss     (3) 
Comprehensive income:602117281278
Other undisclosed comprehensive income (loss), net of tax, attributable to parent17(3)(6)7(5) (8)
Comprehensive income, net of tax, attributable to parent:77181136670

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: